Wolverine Trading’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-11,000
Closed -$659K 7337
2021
Q3
$659K Buy
+11,000
New +$650K ﹤0.01% 3560
2021
Q1
Sell
-7,300
Closed -$567K 6597
2020
Q4
$567K Sell
7,300
-1,900
-21% -$142K ﹤0.01% 3023
2020
Q3
$696K Sell
9,200
-1,000
-10% -$66.7K ﹤0.01% 2443
2020
Q2
$640K Buy
10,200
+1,900
+23% +$105K ﹤0.01% 2476
2020
Q1
$350K Sell
8,300
-22,300
-73% -$1.02M ﹤0.01% 3062
2019
Q4
$1.39M Buy
30,600
+5,000
+20% +$236K ﹤0.01% 2122
2019
Q3
$1.17M Buy
25,600
+11,000
+75% +$618K ﹤0.01% 1843
2019
Q2
$856K Sell
14,600
-5,600
-28% -$289K ﹤0.01% 2193
2019
Q1
$906K Sell
20,200
-500
-2% -$22.9K ﹤0.01% 2176
2018
Q4
$805K Sell
20,700
-16,000
-44% -$628K ﹤0.01% 2171
2018
Q3
$1.69M Sell
36,700
-69,400
-65% -$2.81M ﹤0.01% 1841
2018
Q2
$4.19M Hold
106,100
0.01% 1012
2018
Q1
$4.19M Buy
+106,100
New +$4.13M 0.01% 1012
2017
Q4
Sell
-85,100
Closed -$2.17M 5728
2017
Q3
$2.17M Buy
+85,100
New +$1.95M 0.01% 1271
2016
Q4
Sell
-3,890
Closed -$68K 5408
2016
Q3
$68K Buy
+3,890
New +$64.5K ﹤0.01% 4336

Other funds holding ARNA

Wolverine Trading's ARNA Position: Q4 2020 in Review

Wolverine Trading sold out of Arena Pharmaceuticals Inc (ARNA) in Q4 2020, closing a stake of 10,083 shares — an estimated $756K sold.

Wolverine Trading first reported a position in ARNA in Q3 2017 and held it in 9 quarters. The position peaked at $1.75M in Q2 2018. 254 funds tracked by Wall St. Rank hold ARNA as of Q4 2020.

  • Wolverine Trading reported no remaining Arena Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Wolverine Trading sold 10,083 Arena Pharmaceuticals Inc shares in Q4 2020, an estimated $756K.
  • Wolverine Trading first reported a position in Arena Pharmaceuticals Inc in Q3 2017 and held it in 9 quarters.
  • Wolverine Trading's Arena Pharmaceuticals Inc position peaked at $1.75M in Q2 2018.
  • 254 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q4 2020.

Based on Wolverine Trading's 13F filing for Q4 2020, filed 12 Feb 2021.